Are we ready to use anti-amyloid therapy in Alzheimer's disease?
Sign Up to like & getrecommendations! Published in 2022 at "Arquivos de Neuro-Psiquiatria"
DOI: 10.1590/0004-282x-anp-2022-s117
Abstract: ABSTRACT Alzheimer’s disease (AD) is the most common neurodegenerative disease. Biomarkers have demonstrated that AD pathology exists over the disease continuum from a stage preceding symptoms over 15-25 years to the progressively more impaired symptomatic… read more here.
Keywords: disease; alzheimer disease; amyloid therapy; anti amyloid ... See more keywords